stars 1 stars 2 stars 3

Aurlide Ltd. is a Finnish biotech company, service provider, and strategic partner specializing in computer-aided drug discovery and development (CADD). We offer our in silico expertise throughout all stages of preclinical drug development, from target validation to lead optimization and beyond. Our expertise spans from rational discovery and development of small molecules and macrocycles to first-in-class protein-protein interaction modulators. We also apply predictive toxicology and pharmacokinetics to ensure the success of our clients' drug candidates. Driven by our advanced technology and expertise, we’ve also initiated our own drug discovery projects, pushing the boundaries of therapeutic innovation and creating new opportunities for breakthrough treatments. Looking to innovate? Reach out, and let's explore how we can collaborate! "Aurlide – Your molecule, discovered!" Our achievements, shortly: 13 patents (as inventors) 5 clinical candidates for our customers 2 out-licensed PPI modulator discovery projects 100+ publications

Aurlide ltd. Questions

Sakari Lätti is the COO and Co-founder of Aurlide ltd..

4 people are employed at Aurlide ltd..

Aurlide ltd. is based in Turku, Southwest Finland.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users